News Summary

• Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy.
• Abbott Laboratories had US$13.5b of debt at June 2025, down from US$14.8b a year prior.
• It has a cash reserve of US$7.28b, so its net debt is less, at about US$6.19b.
• The company's interest cover ratio suggests it can handle its debt as easily as Cristiano Ronaldo could score a goal against an under 14's goalkeeper.